Search

Search Constraints

You searched for: Author/Creator Lahat, A

Search Results

1. DOP62 A novel formulation of CT-P13 (infliximab biosimilar) for subcutaneous administration: 1-year result from a Phase I open-label randomised controlled trial in patients with active Crohn's disease. (25th January 2019)

2. DOP36 Gut microbial variations in patients with quiescent Crohn's disease predict subsequent disease flare. (25th January 2019)

3. P190 Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with Quiescent Small Bowel Crohn's disease. (16th January 2018)

4. P277 A new pan enteric capsule for suspected or established IBD: A feasibility study assessing the system functionality to visualise and assess the small and large bowels. (16th January 2018)

5. P486 Response to vedolizumab therapy in patients with inflammatory bowel disease: Impact of drug levels, anti-drug antibodies and α4β7 target occupancy. (16th January 2018)

6. P755 Safety, efficacy, and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-TNF. (16th January 2018)

7. P392 Comprehensive video capsule endoscopy-based monitoring predicts short and long-term risk of disease flares in small bowel Crohn's disease: A prospective cohort study. (16th January 2018)